SENA JUNIOR, Ailton Santos; NASCIMENTO, Bárbara Melo Santos do; TELLES, Ênio Pereira; SILVA, Luiz André Santos; LIRA, Ana Amélia Moreira. Efeitos da suplementação de cúrcuma longa em pacientes com câncer: uma revisão integrativa. Brazilian Journal of Health Review, Curitiba, v. 6, n. 6, p. 33239-33251, nov./dez. 2023. DOI: 10.34119/bjhrv6n6-514.

BAYET-ROBERT, M. et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biology & Therapy, v. 9, n. 1, p. 8–14, 2010. DOI: https://doi.org/10.4161/cbt.9.1.10392.

HEJAZI, J. et al. Effect of curcumin supplementation during radiotherapy on oxidative status of patients with prostate cancer: a double-blinded, randomized, placebo-controlled study. Nutrition and Cancer, v. 68, n. 1, p. 77–85, 2016. DOI: https://doi.org/10.1080/01635581.2016.1115527.

JAMES, M. I. et al. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Cancer Letters, v. 364, n. 2, p. 135–141, 2015. DOI: https://doi.org/10.1016/j.canlet.2015.05.005.